• Mashup Score: 1

    A gene test already used routinely in the NHS can guide use of chemotherapy in people with bowel cancer by predicting whether or not they will benefit.

    Tweet Tweets with this article
    • 🧬NEWS: A gene test already used routinely in the NHS can guide use of #chemotherapy for people with advanced #BowelCancer by predicting whether or not they will benefit. The test offers the prospect of a more #PersonalisedMedicine approach to chemo. https://t.co/75fdk1XZ3a

  • Mashup Score: 0

    Background A small but significant reduction in left ventricular (LV) mass after 18 months of migalastat treatment has been reported in Fabry disease (FD). This study aimed to assess the effect of migalastat on FD cardiac involvement, combining LV morphology and tissue characterisation by cardiac magnetic resonance (CMR) with cardiopulmonary exercise testing (CPET). Methods Sixteen…

    Tweet Tweets with this article
    • #Fabry Disease - New treatment trial (MAIORA study) Migalastat stabilised cardiac mass & trend towards an ⬆️ exercise tolerance 👀 https://t.co/NeO4Or0FTN #Genetics #PersonalisedMedicine #CardioTwitter @MPSSocietyUK @FabryDisease1 @fabryalerts @GuazziMarco @lara89eleven https://t.co/1nqW31iP1z

  • Mashup Score: 0
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • #Hematology Personalized Treatment for Hematologic Diseases in Europe: An ⁦@EHA_Hematology⁩ Position Paper ⁦@Hemasphere_EHA⁩ ⁦⁦@EU_Commission⁩ ⁦@EMA_News⁩ #EuropeanAffairs #PersonalisedMedicine https://t.co/o0sCTgTLR7

  • Mashup Score: 1
    MAP 2022: Registration - 2 year(s) ago

    Registration is open

    Tweet Tweets with this article
    • Last two weeks to register for #MAP2022 to save 📢 Watch what you can expect from this year’s leading global meeting in #personalisedmedicine, live in Amsterdam & online (14-16 Oct). 🔗 https://t.co/9ruIGUJMNQ #precisiononcology @FAndreMD @GroupeUnicancer @CRUKresearch https://t.co/SR5pHqL2rE

  • Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • 94% #Rheumatologists recommend #Virtual Learning Collaborative for #TreatToTarget in #RheumatoidArthritis FREE TO READ THIS MONTH https://t.co/tTcEqzJvAO #rheumatology #RA #immunology #targetedtherapy #personalisedmedicine https://t.co/sfAVqDaLjV

  • Mashup Score: 0
    Bladder Cancer | ESMO - 2 year(s) ago

    Bladder Cancer: ESMO Clinical Practice Guidelines

    Tweet Tweets with this article
    • Just out: updated ESMO Guidelines with key recommendations for the diagnosis, staging & management of #BladderCancer, including practical guidance for #personalisedmedicine 👉 https://t.co/jS940RKr6L @evacomperat @AndreaNecchi @tompowles1 @b_szabados @Annals_Oncology #blcsm https://t.co/bjocKezdiO

  • Mashup Score: 6

    As the complexity of the cancer landscape increases, miscommunication and misunderstanding emerge as major obstacles to patient self-determination

    Tweet Tweets with this article
    • Patients need more support to navigate #precisiononcology: with #personalisedmedicine poorly understood, #healthcommunication becomes crucial for #patientempowerment 🔎 Learn more in #ESMOPerspectives https://t.co/DJMvrQr73g @jillfeldman4 @DrSanjayPopat https://t.co/45zBdnsT2F